A New Revolutionary 3-Injection- Protocol in Infertile Women
NCT03877185 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-10-08
Summary
This is a prospective randomised study of the evaluation of the clinical IVF results after following a new revolutionary 3-Injection- Protocol for controlled ovarian stimulation in infertile women.
Conditions
- Infertility, Female
Interventions
- DIAGNOSTIC_TEST
-
Live birth rate
Live Birth Rate and Blastulation Rate according to the protocol of COS
Sponsors & Collaborators
-
Assisting Nature
lead OTHER
Principal Investigators
-
Evaggelos Papanikolaou, MD,PhD · Assisting Nature
-
Robert Najdecki, MD,PhD · Assisting Nature
Eligibility
- Min Age
- 22 Years
- Max Age
- 39 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-07-01
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- Greece
Study Locations
More Related Trials
-
Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation
NCT00417183 ·Status: UNKNOWN ·Phase: PHASE4
-
Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins
NCT02237781 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality
NCT03139474 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients
NCT01973842 ·Status: UNKNOWN ·Phase: PHASE2
-
Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF
NCT01798836 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women
NCT01735422 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation
NCT00633347 ·Status: COMPLETED ·Phase: PHASE4
-
Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix
NCT03240159 ·Status: UNKNOWN ·Phase: PHASE3
-
GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT
NCT02053779 ·Status: COMPLETED ·Phase: PHASE3
-
Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF
NCT02070198 ·Status: UNKNOWN ·Phase: PHASE4
-
Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders
NCT00417066 ·Status: COMPLETED ·Phase: PHASE4
-
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
NCT02312076 ·Status: RECRUITING ·Phase: PHASE4
-
Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG
NCT01638026 ·Status: COMPLETED ·Phase: PHASE4
-
Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles
NCT06150703 ·Status: RECRUITING ·Phase: PHASE3
-
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH
NCT00296465 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Single Follicular Dexarelix for LH Suppression During Ovarian Stimulation in Oocyte Donors.
NCT03861715 ·Status: UNKNOWN
-
Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian Stimulation
NCT03300960 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Medication Used to Stimulate Ovulation
NCT02715336 ·Status: UNKNOWN ·Phase: PHASE4
-
Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?
NCT03353883 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
NCT07216742 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve
NCT05567731 ·Status: COMPLETED ·Phase: NA
-
Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation
NCT02703584 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
NCT05969795 ·Status: RECRUITING ·Phase: PHASE1
-
Ultrashort GnRH Agonist/Antagonist Versus GnRH Antagonist IVF
NCT02173977 ·Status: UNKNOWN ·Phase: PHASE2
-
Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders
NCT01732094 ·Status: COMPLETED ·Phase: PHASE2